Does Allergy Medicine Really Stop Working? The Evidence Says Mostly No
The idea that allergy pills 'stop working' after months of daily use isn't well supported by the evidence — but the FDA has flagged a real, different reaction to watch for when you quit.
"My allergy medicine stopped working" is one of the most common complaints allergists hear, usually from someone who has taken the same cetirizine or loratadine tablet every morning for months or years. The assumption is almost always the same: the body built up a tolerance, sometimes called tachyphylaxis, and it's time to switch pills or double the dose.
The clinical evidence for that assumption is thinner than the folk wisdom around it.
The most direct test followed 37 young men with persistent rhinitis for 180 days, randomly assigned to a daily 10-milligram dose of cetirizine, a daily 5-milligram dose of levocetirizine, or placebo, with 28 completing the full study. Researchers measured how much each drug suppressed a histamine-induced skin reaction, redness and swelling at an injection site, every 30 days. If tolerance were building, that suppression should fade over time.
It didn't. Skin-reaction suppression stayed above 92% and blood-flow suppression stayed above 85% throughout the full 180 days, according to the study, indexed on PubMed under the title "Does new antihistamines characterize tachyphylaxis phenomenon?" The researchers' conclusion was blunt: no tachyphylaxis was observed for either drug across six months of daily use.
That single study isn't the last word; the antihistamine market spans nine second-generation drugs, from bilastine to rupatadine, and no one has run a matching 180-day trial on all of them. But it lines up with the broader clinical record on cetirizine specifically: a 2019 review of three decades of cetirizine research, published in the journal Multidisciplinary Respiratory Medicine, documented the drug's efficacy across seasonal and year-round allergic rhinitis and chronic hives without flagging a tolerance problem serious enough to change how doctors prescribe it.
So why do so many people swear their allergy pills quit on them? Allergists point to reasons that have nothing to do with the drug losing potency: new allergies developing on top of old ones, non-allergic triggers such as smoke or fragrance mimicking allergy symptoms, or a changed environment exposing someone to pollen or dust they weren't dealing with before. None of those is tachyphylaxis, and none is fixed by rotating to a different antihistamine, even though rotating sometimes helps anyway, because the new drug happens to cover a symptom the old one didn't.
There is a real reaction tied to these drugs, though, and it runs in the opposite direction: not while you're taking them, but after you stop.
In May 2025, the FDA required a new warning on cetirizine and levocetirizine, sold as Zyrtec and Xyzal among other names, after reviewing 209 cases worldwide, 197 of them in the U.S., of severe itching that began within days of stopping the medicine following months or years of daily use. The agency's adverse-event database showed a median 33 months of use before the reaction hit, in a range spanning one week to 23 years, with itching starting a median of two days after the last dose.
"Many reports described widespread pruritus that required medical intervention after stopping these medicines, with a large number describing significant and persistent impact on quality of life and ability to function."
FDA Drug Safety Communication, May 16, 2025
The numbers matter here precisely because they're small. Roughly 62.7 million packages of over-the-counter cetirizine and levocetirizine were purchased in the U.S. in 2022 alone, according to the FDA's own data in that same safety communication, against which 209 reported cases over six years is a rare event, not a reason to panic about a medicine millions of people take safely. But the review did find a workable pattern: restarting the medicine resolved the itching in 90% of people who tried it, and the risk climbed with duration of use, with 92% of reported cases involving more than three months of continuous use.
Put the two findings side by side and the practical guidance for a worried reader is fairly simple. If a daily antihistamine seems to be doing less than it used to, the evidence points toward something else changing, a new trigger, a new season, a non-allergic irritant, rather than the pill itself losing strength, and it's worth a conversation with a doctor or pharmacist about which over-the-counter option actually fits the trigger. And if the plan is to stop a cetirizine or levocetirizine habit that's run for months or years, tapering off gradually rather than quitting cold, the approach that resolved symptoms in some FDA-reported cases, is a reasonable low-cost precaution against a risk that remains, by the numbers, rare.
